aurintricarboxylic acid has been researched along with e 3330 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cholia, RP; Kaur, G; Kumar, R; Mantha, AK | 1 |
| Laev, SS; Lavrik, OI; Salakhutdinov, NF | 1 |
1 review(s) available for aurintricarboxylic acid and e 3330
| Article | Year |
|---|---|
Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Enzyme Inhibitors; Humans; Neoplasms; Oxidation-Reduction | 2017 |
1 other study(ies) available for aurintricarboxylic acid and e 3330
| Article | Year |
|---|---|
DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
Topics: Antineoplastic Agents; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Drug Design; Humans; Neoplasms; Oxidation-Reduction | 2014 |